BASAL CELL CARCINOMA

This adverse event was reported 15617 times

These drugs are most commonly taken by patients reporting BASAL CELL CARCINOMA:

# Drug Count
0 METHOTREXATE SODIUM 2187
1 INFLIXIMAB 1970
2 METHOTREXATE 1965
3 ADALIMUMAB 1945
4 PREDNISONE 1519
5 ETANERCEPT 1378
6 RITUXIMAB 1095
7 ALENDRONATE SODIUM 1031
8 FOLIC ACID 940
9 ASPIRIN 920
See all common drugs associated with BASAL CELL CARCINOMA

BASAL CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE 14 0.0903
1 AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE 21 0.0814
2 GOLIMUMAB 515 0.0409
3 GOLD 163 0.0281
4 ERGOCALCIFEROL 799 0.0269
5 BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE 15 0.0242
6 INFLIXIMAB-DYYB 73 0.0212
7 BREXUCABTAGENE AUTOLEUCEL 45 0.0209
8 PSYLLIUM HUSK 23 0.0170
9 VISMODEGIB 142 0.0159
See all drugs enriched for association with BASAL CELL CARCINOMA